SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001906324-24-000021
Filing Date
2024-04-29
Accepted
2024-04-29 08:00:19
Documents
15
Period of Report
2024-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20240425.htm   iXBRL 8-K 34904
2 EX-10.1 exhibit101-amendmentno2.htm EX-10.1 138088
  Complete submission text file 0001906324-24-000021.txt   340051

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20240425.xsd EX-101.SCH 2249
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20240425_def.xml EX-101.DEF 14433
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20240425_lab.xml EX-101.LAB 25398
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20240425_pre.xml EX-101.PRE 15008
18 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20240425_htm.xml XML 2704
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

IRS No.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 24886646
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)